An open label pilot study on the tolerability of duloxetine in the treatment of depressed patients with Parkinson s disease

Registry ID

EUCTR2006-006043-32

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

ELI LILLY

Start date

2007-02-21

Last update

2026-08-16

Conditions

• outpatient

Summary

The primary objective of this study is to assess the tolerability of duloxetine 60 mg once daily QD , given in an open label fashion, in the treatment of depression in patients with PD, after 12 weeks treatment.

Locations

• , , Italy

View on source registry